Get a Quote

Category: Remote Patient Monitoring

Latest Articles

Healthcare Mergers and Acquisitions Trends 2026: The Revenue Risk Deal Models Miss

Key Takeaways Healthcare M&A deal value fell to an estimated $46 billion in 2025 from $62 billion in 2024, and early 2026 brought slightly fewer...

Healthcare Acquisitions and the Cash Flow Gap Nobody Budgets For

Key Takeaways In healthcare acquisitions, the cash flow gap is the time between the close date and the first clean claim paid to the new...

Mergers and Acquisitions in Healthcare: What Happens to Payer Enrollment When a Practice Is Sold

Key Takeaways Physicians and physician groups must report a change of ownership to Medicare within 30 days, and a deal that changes the tax ID...

BCBS Prior Auth: A Provider’s Guide to Blue Cross Blue Shield Prior Authorization in 2026

Key Takeaways BCBS prior auth has no single national process. The Blue Cross Blue Shield Association is a federation of 33 independent companies, and each...

Prior Authorization for Dermatology: What Practices Need to Know in 2026

Key Takeaways GLP-1s require prior authorization because the same drug can be covered or excluded depending on the diagnosis it’s prescribed for, not the drug...

Neolytix Identifies an Average of $341K in Payer Contract Revenue Opportunities — Get Your Assessment Done Today

Beyond Prior Auth:

Closing the GLP-1 Access

A working session with the CEO of Neolytix and CMO of PrescriberPoint on improving first-pass approvals and shortening time-to-treatment.

Keynote Speakers

Raj Bhatnagar

Chief Executive Officer, Neolytix

Dr. Steve Strongwater
Chief Medical Officer, PrescriberPoint